secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2021-08-09T23:59:59+00:00
Accession:  0001104659-21-102285
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience appoints drug discovery leader Melissa Starovasnik to board
----------------------------------------------------------------------------

- Dr. Starovasnik appointed to board effective Aug 5, 2021; will receive $40k cash retainer (pro rata) and $340k in equity vesting over 3 years.
- She spent nearly 30 years at Genentech, most recently as Senior Scientific Advisor, leading protein therapeutics discovery.
- Kevin Yankton appointed principal accounting officer; previously Chief Accounting Officer at Varex Imaging; James Thorburn remains CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465921102285/0001104659-21-102285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465921102285/tm2124344d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-102285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer